Michael Schnaubelt Selected Research

Proteins (Proteins, Gene)

10/2022	Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.
1/2021	Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
12/2020	Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.
6/2020	Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes.
1/2020	Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry.
1/2020	Impact of Increased FUT8 Expression on the Extracellular Vesicle Proteome in Prostate Cancer Cells.
1/2020	Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems.
1/2019	Simple Tip-Based Sample Processing Method for Urinary Proteomic Analysis.
1/2018	Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Schnaubelt Research Topics

Disease

12	Neoplasms (Cancer) 10/2022 - 01/2018
4	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2017
3	Adenocarcinoma 10/2022 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 06/2020
2	Chromosomal Instability (Chromosome Stability) 01/2020 - 01/2020
1	renal Oncocytoma 04/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Pathologic Processes 01/2022
1	Carcinoma (Carcinomatosis) 12/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Glioma (Gliomas) 01/2021
1	Disease Progression 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Urologic Diseases (Urinary Tract Disease) 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2018
6	ProteomeIBA 12/2021 - 01/2018
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2020
3	GlycopeptidesIBA 12/2021 - 01/2019
3	Phenobarbital (Luminal)FDA Link 01/2020 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2021
2	EnzymesIBA 12/2020 - 10/2020
2	Peptides (Polypeptides)IBA 06/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
1	NectinsIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	trametinibIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Polysaccharides (Glycans)IBA 12/2020
1	Histones (Histone)IBA 01/2020
1	PhosphopeptidesIBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2020
2	Precision Medicine 12/2020 - 01/2020
1	Lasers (Laser) 10/2022